Bile duct cancer, also known as cholangiocarcinoma (CCA), is a rare cancer often diagnosed only at an advanced stage. A comprehensive analysis of diagnostic, prognostic, and therapeutic aspects of over 2,200 patients in Europe now provides a valuable knowledge base for raising awareness and managing CCA to improve outcomes.
Click here for original story, Initiative to map the cholangiocarcinoma (CCA) landscape in Europe will help improve patient outcomes
Source: ScienceDaily